A 59-year-old with type 2 diabetes and BMI 36 kg/m² asks about weight-loss pharmacotherapy with CV benefit. Which agent class has proven CV event redu...

Question

A 59-year-old with type 2 diabetes and BMI 36 kg/m² asks about weight-loss pharmacotherapy with CV benefit. Which agent class has proven CV event reduction?

Accepted Answer

GLP-1 receptor agonists (e.g., semaglutide)

Answer

DPP-4 inhibitors

Answer

Sulfonylureas

Answer

Alpha-glucosidase inhibitors

Answer

Meglitinides

us-abfm MCQ (SBA): Type 2 Diabetes Risk Reduction

A 59-year-old with type 2 diabetes and BMI 36 kg/m² asks about weight-loss pharmacotherapy with CV benefit. Which agent class has proven CV event reduction?